EMagin Valuation

EMANDelisted Stock  USD 2.00  0.01  0.50%   
Based on Macroaxis valuation methodology, the firm appears to be overvalued. EMagin shows a prevailing Real Value of $1.62 per share. The current price of the firm is $2.0. Our model computes the value of EMagin from inspecting the firm fundamentals such as Operating Margin of (0.50) %, profit margin of (0.48) %, and Current Valuation of 183.72 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
2.00
Please note that EMagin's price fluctuation is very steady at this time. Calculation of the real value of EMagin is based on 3 months time horizon. Increasing EMagin's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since EMagin is currently traded on the exchange, buyers and sellers on that exchange determine the market value of EMagin Stock. However, EMagin's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  2.0 Real  1.62 Hype  2.0
The intrinsic value of EMagin's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence EMagin's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
1.61
Real Value
2.20
Upside
Estimating the potential upside or downside of EMagin helps investors to forecast how EMagin stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of EMagin more accurately as focusing exclusively on EMagin's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
2.002.002.00
Details

EMagin Total Value Analysis

EMagin is currently forecasted to have valuation of 183.72 M with market capitalization of 172.2 M, debt of 15.93 M, and cash on hands of 3.86 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the EMagin fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
183.72 M
172.2 M
15.93 M
3.86 M

EMagin Investor Information

About 16.0% of the company shares are held by institutions such as insurance companies. The book value of EMagin was currently reported as 0.14. The company recorded a loss per share of 0.16. EMagin last dividend was issued on the 18th of December 2012. The entity had 1:10 split on the 3rd of November 2006. Based on the analysis of EMagin's profitability, liquidity, and operating efficiency, EMagin is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.

EMagin Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. EMagin has an asset utilization ratio of 41.76 percent. This suggests that the Company is making $0.42 for each dollar of assets. An increasing asset utilization means that EMagin is more efficient with each dollar of assets it utilizes for everyday operations.

EMagin Ownership Allocation

EMagin holds a total of 83.19 Million outstanding shares. EMagin shows 6.88 percent of its outstanding shares held by insiders and 15.97 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

EMagin Profitability Analysis

The company reported the previous year's revenue of 30.53 M. Net Loss for the year was (1.1 M) with profit before overhead, payroll, taxes, and interest of 10.32 M.

About EMagin Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of EMagin. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of EMagin based exclusively on its fundamental and basic technical indicators. By analyzing EMagin's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of EMagin's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of EMagin. We calculate exposure to EMagin's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of EMagin's related companies.
eMagin Corporation engages in the design, develop, manufacture, and market of organic light-emitting diode miniature displays on-silicon micro displays, virtual imaging products that utilize OLED micro displays, and related products in the United States and internationally. The company was founded in 1996 and is headquartered in Hopewell Junction, New York. Emagin Corp operates under Electronic Components classification in the United States and is traded on AMEX Exchange. It employs 101 people.

EMagin Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding75.6 M
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Consideration for investing in EMagin Stock

If you are still planning to invest in EMagin check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EMagin's history and understand the potential risks before investing.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities